REGN : REGENERON PHARMACEUTICALS stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2024-09-06 |
|---|---|---|---|---|
| 2024 | $1227.8 | $1179.68 | $1273.83 | 8.51% |
| 2025 | $1535.23 | $1319.96 | $1629.31 | 35.68% |
| 2026 | $1089.45 | $921.55 | $1478.74 | -3.72% |
| 2027 | $752.1 | $601.9 | $850.99 | -33.53% |
| 2028 | $730.48 | $572.79 | $929.99 | -35.44% |
| 2029 | $1168.0 | $842.28 | $1303.7 | 3.23% |
| 2030 | $1104.15 | $765.19 | $1334.39 | -2.42% |
| 2031 | $716.99 | $629.5 | $779.72 | -36.63% |
| 2032 | $537.37 | $504.21 | $599.82 | -52.51% |
| 2033 | $450.88 | $384.22 | $548.08 | -60.15% |
| 2034 | $307.03 | $278.62 | $366.66 | -72.87% |
The 33 Wall Street analysts offering REGENERON PHARMACEUTICALS stock forecast in the last 6 months have average price target of
$1136.61 with a high forecast of $1300.0 and a low forecast of $720.0.
The average REGENERON PHARMACEUTICALS stock forecast represents a 0.45%
increase from the last price of $1131.5.
For REGENERON PHARMACEUTICALS stock forecast for 2024, 3 predictions are offered for each month of 2024 with average REGENERON PHARMACEUTICALS stock
forecast of $1227.8, a high forecast of $1273.83, and a low forecast of $1179.68.
The average REGENERON PHARMACEUTICALS stock forecast 2024 represents a 8.51%
increase from the last price of $1131.5.
For REGENERON PHARMACEUTICALS stock forecast for 2025, 12 predictions are offered for each month of 2025 with average REGENERON PHARMACEUTICALS stock
forecast of $1535.23, a high forecast of $1629.31, and a low forecast of $1319.96.
The average REGENERON PHARMACEUTICALS stock forecast 2025 represents a 35.68%
increase from the last price of $1131.5.
For REGENERON PHARMACEUTICALS stock forecast for 2027, 12 predictions are offered for each month of 2027 with average REGENERON PHARMACEUTICALS stock
forecast of $752.1, a high forecast of $850.99, and a low forecast of $601.9.
The average REGENERON PHARMACEUTICALS stock forecast 2027 represents a -33.53%
decrease from the last price of $1131.5.
For REGENERON PHARMACEUTICALS stock forecast for 2029 (5 year), 12 predictions are offered for each month of 2029 with average REGENERON PHARMACEUTICALS stock
forecast of $1168.0, a high forecast of $1303.7, and a low forecast of $842.28.
The average REGENERON PHARMACEUTICALS stock forecast 2029 represents a 3.23%
increase from the last price of $1131.5.
For REGENERON PHARMACEUTICALS stock forecast 2030, 12 predictions are offered for each month of 2030 with average REGENERON PHARMACEUTICALS stock
forecast of $1104.15, a high forecast of $1334.39, and a low forecast of $765.19.
The average REGENERON PHARMACEUTICALS stock forecast 2030 represents a -2.42%
decrease from the last price of $1131.5.
For REGENERON PHARMACEUTICALS stock forecast for 2034 (10 year), 9 predictions are offered for each month of 2034 with average REGENERON PHARMACEUTICALS stock
forecast of $307.03, a high forecast of $366.66, and a low forecast of $278.62.
The average REGENERON PHARMACEUTICALS stock forecast 2034 represents a -72.87%
decrease from the last price of $1131.5.
Please, see more forecasts below.
REGN : REGENERON PHARMACEUTICALS stock forecast by Wall Street Analysts
The average REGENERON PHARMACEUTICALS stock forecast from last 6 month is $1136.61, and this show a 4.9% increase in average from the prior price target of the each prediction. Also, this average forecast of $1136.61 represents a 18.17% increase from the past average forecast of $961.87, 6 months ago from 23 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-09-05 | RBC Capital | $1250.0000 | $1250.00 | Outperform |
| 2024-08-23 | Piper Sandler | $1166.00 | $1242 | Overweight |
| 2024-08-02 | Truist Securities | $1135.00 | $1200.0000 | Buy |
| 2024-08-02 | Barclays | $1200.00 | $1220.0000 | Overweight |
| 2024-08-02 | Wells Fargo | $1125.0000 | $1200.0000 | Overweight |
| 2024-08-02 | Guggenheim | $1180.00 | $1300.00 | Buy |
| 2024-08-02 | RBC Capital | $1232.0000 | $1240 | Outperform |
| 2024-08-02 | JP Morgan | $1150.00 | $1200.0000 | Overweight |
| 2024-07-23 | TD Cowen | $1030.00 | $1200.0000 | Buy |
| 2024-07-22 | Cantor Fitzgerald | $925.00 | $1000.0000 | Neutral |
| 2024-07-19 | Piper Sandler | $1000.0000 | $1166 | Overweight |
| 2024-07-18 | Guggenheim | $1040.0000 | $1180.0000 | Buy |
| 2024-07-11 | Morgan Stanley | $1183.0000 | $1182 | Overweight |
| 2024-07-10 | Barclays | $1050.0000 | $1200.0000 | Overweight |
| 2024-06-27 | Canaccord Genuity | $1152.0000 | $1152.0000 | Buy |
| 2024-06-25 | Argus Research | $1060.0000 | $1170.0000 | Buy |
| 2024-06-24 | RBC Capital | $1229.00 | $1229.00 | Outperform |
| 2024-06-17 | JP Morgan | $1050.0000 | $1150.0000 | Overweight |
| 2024-06-12 | RBC Capital | $1200.0000 | $1229.0000 | Outperform |
| 2024-06-04 | RBC Capital | $1185.0000 | $1200.00 | Outperform |
| 2024-05-14 | Evercore ISI Group | $1150.0000 | Outperform | |
| 2024-05-03 | Cantor Fitzgerald | $925.0000 | Neutral | |
| 2024-04-24 | TD Cowen | $1020.0000 | $1030.0000 | Buy |
| 2024-04-17 | UBS | $1090.0000 | $1099.0000 | Buy |
| 2024-04-17 | Cantor Fitzgerald | $925.0000 | Neutral | |
| 2024-04-15 | Cantor Fitzgerald | $925.0000 | Neutral | |
| 2024-04-12 | B of A Securities | $710.0000 | $720.0000 | Underperform |
| 2024-04-09 | RBC Capital | $1189.0000 | Outperform | |
| 2024-04-03 | Truist Securities | $1135.00 | $1135 | Buy |
| 2024-03-26 | Truist Securities | $1135.0000 | $1135 | Buy |
| 2024-03-13 | Morgan Stanley | $1104.0000 | $1115 | Overweight |
| 2024-03-12 | Bernstein | $1125.0000 | Outperform | |
| 2024-03-11 | Bernstein | $1125.0000 | Outperform | |
| 2024-02-27 | RBC Capital | $1096.0000 | $1184.0000 | Outperform |
| 2024-02-06 | Cantor Fitzgerald | $850.0000 | $925.0000 | Neutral |
| 2024-02-05 | BMO Capital | $1055.0000 | $1082.00 | Outperform |
| 2024-02-05 | RBC Capital | $1076.00 | $1110.0000 | Outperform |
| 2024-01-29 | RBC Capital | $1076.0000 | Outperform | |
| 2024-01-23 | Barclays | $935.0000 | $1020 | Overweight |
| 2024-01-12 | RBC Capital | $1076.0000 | Outperform | |
| 2024-01-09 | Cantor Fitzgerald | $850.0000 | Neutral | |
| 2023-12-18 | Truist Securities | $1045.0000 | Buy | |
| 2023-12-06 | TD Cowen | $900.0000 | $1000.0000 | Outperform |
| 2023-11-29 | Truist Securities | $1045.0000 | Buy | |
| 2023-11-28 | Truist Securities | $1045.0000 | Buy | |
| 2023-11-28 | Jefferies | $935.0000 | $937 | Buy |
| 2023-11-09 | Deutsche Bank | $800.0000 | Hold | |
| 2023-11-03 | Raymond James | $950.0000 | Outperform | |
| 2023-11-03 | Morgan Stanley | $915.0000 | $914 | Overweight |
| 2023-11-03 | RBC Capital | $847.0000 | $837.0000 | Sector Perform |
| 2023-11-03 | Piper Sandler | $885.0000 | $895 | Overweight |
| 2023-10-16 | Cantor Fitzgerald | $800.00 | $850.0000 | Neutral |
| 2023-10-12 | RBC Capital | $833.0000 | $847.0000 | Sector Perform |
| 2023-10-11 | Morgan Stanley | $912.00 | $915 | Overweight |
| 2023-09-21 | Cantor Fitzgerald | $800.0000 | Neutral | |
| 2023-09-15 | Argus Research | $825.0000 | $920 | Buy |
| 2023-09-15 | WestPark Capital | Hold |
REGENERON PHARMACEUTICALS stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2024-09-09 | $1126.06 | -0.48% |
| 2024-09-10 | $1119.14 | -0.62% |
| 2024-09-11 | $1116.83 | -0.21% |
| 2024-09-12 | $1103.87 | -1.16% |
| 2024-09-13 | $1091.51 | -1.12% |
REGN : Long term REGENERON PHARMACEUTICALS stock forecast for 2024 - 2025 - 2030
Forecast for 2024 Oct. is $1179.68 , for 2025 Sep. is $1629.31 , for 2028 Sep. is $916.52 , for 2029 Sep. is $1248.65 , for 2033 Sep. is $418.85 , and for 2034 Sep. is $278.62.
REGN : REGENERON PHARMACEUTICALS stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Oct. | $1179.68 | 4.26% |
| 2024 Nov. | $1229.89 | 4.26% |
| 2024 Dec. | $1273.83 | 3.57% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $1319.96 | 3.62% |
| 2025 Feb. | $1374.81 | 4.16% |
| 2025 Mar. | $1445.26 | 5.12% |
| 2025 Apr. | $1509.83 | 4.47% |
| 2025 May. | $1557.99 | 3.19% |
| 2025 Jun. | $1593.19 | 2.26% |
| 2025 Jul. | $1612.30 | 1.20% |
| 2025 Aug. | $1613.16 | 0.05% |
| 2025 Sep. | $1629.31 | 1.00% |
| 2025 Oct. | $1613.39 | -0.98% |
| 2025 Nov. | $1598.30 | -0.94% |
| 2025 Dec. | $1555.28 | -2.69% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $1478.74 | -4.92% |
| 2026 Feb. | $1380.62 | -6.64% |
| 2026 Mar. | $1268.81 | -8.10% |
| 2026 Apr. | $1167.72 | -7.97% |
| 2026 May. | $1066.52 | -8.67% |
| 2026 Jun. | $992.80 | -6.91% |
| 2026 Jul. | $957.82 | -3.52% |
| 2026 Aug. | $951.17 | -0.69% |
| 2026 Sep. | $968.56 | 1.83% |
| 2026 Oct. | $967.90 | -0.07% |
| 2026 Nov. | $951.15 | -1.73% |
| 2026 Dec. | $921.55 | -3.11% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $850.99 | -7.66% |
| 2027 Feb. | $821.23 | -3.50% |
| 2027 Mar. | $813.13 | -0.99% |
| 2027 Apr. | $811.90 | -0.15% |
| 2027 May. | $814.81 | 0.36% |
| 2027 Jun. | $811.92 | -0.35% |
| 2027 Jul. | $792.00 | -2.45% |
| 2027 Aug. | $742.73 | -6.22% |
| 2027 Sep. | $689.03 | -7.23% |
| 2027 Oct. | $651.63 | -5.43% |
| 2027 Nov. | $623.89 | -4.26% |
| 2027 Dec. | $601.90 | -3.52% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $586.09 | -2.63% |
| 2028 Feb. | $577.18 | -1.52% |
| 2028 Mar. | $572.89 | -0.74% |
| 2028 Apr. | $572.79 | -0.02% |
| 2028 May. | $584.06 | 1.97% |
| 2028 Jun. | $644.13 | 10.29% |
| 2028 Jul. | $873.60 | 35.62% |
| 2028 Aug. | $929.99 | 6.46% |
| 2028 Sep. | $916.52 | -1.45% |
| 2028 Oct. | $870.92 | -4.98% |
| 2028 Nov. | $826.08 | -5.15% |
| 2028 Dec. | $811.46 | -1.77% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $842.28 | 3.80% |
| 2029 Feb. | $910.76 | 8.13% |
| 2029 Mar. | $1010.12 | 10.91% |
| 2029 Apr. | $1119.17 | 10.80% |
| 2029 May. | $1217.66 | 8.80% |
| 2029 Jun. | $1285.00 | 5.53% |
| 2029 Jul. | $1303.70 | 1.46% |
| 2029 Aug. | $1267.80 | -2.75% |
| 2029 Sep. | $1248.65 | -1.51% |
| 2029 Oct. | $1247.54 | -0.09% |
| 2029 Nov. | $1266.13 | 1.49% |
| 2029 Dec. | $1297.24 | 2.46% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $1326.19 | 2.23% |
| 2030 Feb. | $1334.39 | 0.62% |
| 2030 Mar. | $1318.25 | -1.21% |
| 2030 Apr. | $1285.75 | -2.46% |
| 2030 May. | $1233.35 | -4.08% |
| 2030 Jun. | $1169.96 | -5.14% |
| 2030 Jul. | $1115.65 | -4.64% |
| 2030 Aug. | $1051.26 | -5.77% |
| 2030 Sep. | $968.93 | -7.83% |
| 2030 Oct. | $884.81 | -8.68% |
| 2030 Nov. | $796.06 | -10.03% |
| 2030 Dec. | $765.19 | -3.88% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $774.80 | 1.26% |
| 2031 Feb. | $779.72 | 0.64% |
| 2031 Mar. | $743.65 | -4.63% |
| 2031 Apr. | $722.77 | -2.81% |
| 2031 May. | $720.65 | -0.29% |
| 2031 Jun. | $720.72 | 0.01% |
| 2031 Jul. | $719.12 | -0.22% |
| 2031 Aug. | $718.21 | -0.13% |
| 2031 Sep. | $714.73 | -0.48% |
| 2031 Oct. | $696.99 | -2.48% |
| 2031 Nov. | $663.00 | -4.88% |
| 2031 Dec. | $629.50 | -5.05% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $599.82 | -4.72% |
| 2032 Feb. | $574.67 | -4.19% |
| 2032 Mar. | $556.24 | -3.21% |
| 2032 Apr. | $541.08 | -2.72% |
| 2032 May. | $529.12 | -2.21% |
| 2032 Jun. | $520.11 | -1.70% |
| 2032 Jul. | $513.57 | -1.26% |
| 2032 Aug. | $508.19 | -1.05% |
| 2032 Sep. | $504.21 | -0.78% |
| 2032 Oct. | $506.79 | 0.51% |
| 2032 Nov. | $533.44 | 5.26% |
| 2032 Dec. | $561.17 | 5.20% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $548.08 | -2.33% |
| 2033 Feb. | $523.63 | -4.46% |
| 2033 Mar. | $498.01 | -4.89% |
| 2033 Apr. | $472.48 | -5.13% |
| 2033 May. | $453.96 | -3.92% |
| 2033 Jun. | $443.02 | -2.41% |
| 2033 Jul. | $435.20 | -1.76% |
| 2033 Aug. | $427.48 | -1.78% |
| 2033 Sep. | $418.85 | -2.02% |
| 2033 Oct. | $408.70 | -2.42% |
| 2033 Nov. | $396.97 | -2.87% |
| 2033 Dec. | $384.22 | -3.21% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $366.66 | -4.57% |
| 2034 Feb. | $342.91 | -6.48% |
| 2034 Mar. | $321.82 | -6.15% |
| 2034 Apr. | $306.14 | -4.87% |
| 2034 May. | $294.62 | -3.76% |
| 2034 Jun. | $287.71 | -2.35% |
| 2034 Jul. | $283.71 | -1.39% |
| 2034 Aug. | $281.03 | -0.95% |
| 2034 Sep. | $278.62 | -0.85% |
Frequently Asked Questions about REGENERON PHARMACEUTICALS stock forecast
Is REGENERON PHARMACEUTICALS a good long term stock?
From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2024 Oct. is $1179.68393391269 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2025 Sep. is $1629.31179430305 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2028 Sep. is $916.51754938403 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2029 Sep. is $1248.65122023647 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2033 Sep. is $418.846523914624 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2034 Sep. is $278.624184243027
Is REGENERON PHARMACEUTICALS stock overvalued?
REGENERON PHARMACEUTICALS (REGN) stock is expected to go UP . Therefore, AIPickup would say that REGENERON PHARMACEUTICALS (REGN) stock is NOT overvalued.
Will REGENERON PHARMACEUTICALS stock price go up?
Yes. The REGENERON PHARMACEUTICALS stock price forecast for 2025 Sep. is $1629.31179430305
Is REGENERON PHARMACEUTICALS stock a good buy now?
Since closing price on 2024-09-06 is $1131.5 and forecast for 2025 Sep. is $1629.31, REGENERON PHARMACEUTICALS stock is a good 1 year investment.
14 Days Historical Data for REGENERON PHARMACEUTICALS stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| REGN stock price for 2024-08-19 | $1196.88 | $1180.02 | $1178.18 | $1197.69 |
| REGN stock price for 2024-08-20 | $1192.23 | $1196.88 | $1185.87 | $1201.59 |
| REGN stock price for 2024-08-21 | $1185.34 | $1194.71 | $1184.03 | $1203.49 |
| REGN stock price for 2024-08-22 | $1187.66 | $1189.70 | $1180.00 | $1191.84 |
| REGN stock price for 2024-08-23 | $1199.12 | $1195.72 | $1190.00 | $1202.24 |
| REGN stock price for 2024-08-26 | $1199.37 | $1199.12 | $1195.67 | $1206.81 |
| REGN stock price for 2024-08-27 | $1201.76 | $1199.34 | $1197.13 | $1211.20 |
| REGN stock price for 2024-08-28 | $1199.29 | $1196.06 | $1190.17 | $1206.66 |
| REGN stock price for 2024-08-29 | $1178.93 | $1204.72 | $1175.46 | $1210.97 |
| REGN stock price for 2024-08-30 | $1184.69 | $1179.20 | $1170.84 | $1191.33 |
| REGN stock price for 2024-09-03 | $1168.81 | $1178.73 | $1162.87 | $1192.54 |
| REGN stock price for 2024-09-04 | $1179.37 | $1168.81 | $1163.35 | $1182.31 |
| REGN stock price for 2024-09-05 | $1150.56 | $1175.16 | $1143.24 | $1175.16 |
| REGN stock price for 2024-09-06 | $1131.50 | $1150.00 | $1128.97 | $1152.87 |